FindTrial
Sign In

A registry study of the incidence of postherpetic neuralgia

A registry study of the incidence of postherpetic neuralgia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045232
Enrollment
Unknown
Registered
2021-04-08
Start date
2021-04-10
Completion date
Unknown
Last updated
2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

case series:No intervention

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with herpes zoster diagnosed definitively by an experienced dermatologist; 2. Patients were informed that the extent of their disease, treatment regimen, and changes in efficacy will be anonymously analyzed statistically at a later date to obtain the patient's informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe pain other than PHN; 2. Patients suffering from severe mental illness or unable to cooperate during the test.

Design outcomes

Primary

MeasureTime frame
Proportion of patients diagnosed with posterior neuralgia after 4 months of herpes zoster rash;—

Countries

China

Contacts

Public ContactZhang Haiping

Xuanwu Hospital Capital Medical University

zhanghaiping@xwh.ccmu.edu.cn+86 10 83198961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026